Tactics of topical therapy for cutaneous vasculitis in rheumatoid arthritis


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

One of the extra-articular systemic manifestations of rheumatoid arthritis (RA) is cutaneous rheumatoid vasculitis (RV). Among the reasons for the development of RV, an important place is occupied by the deposition of immune complexes in the walls of blood vessels. This concept is based on the detection of high titers of rheumatoid factor, circulating immune complexes, as well as cryoglobulins in most RA patients with RV. Along with the use of disease-modifying anti-rheumatic drug therapy, topical treatment plays a significant role.

全文:

受限制的访问

作者简介

David Bestaev

North Ossetian State Medical Academy

Email: davidbestaev@rambler.ru
MD, Head of the Department of Internal Diseases № 3 Vladikavkaz, Russia

S. Ktsoeva

North Ossetian State Medical Academy

Vladikavkaz, Russia

Z. Brtsieva

North Ossetian State Medical Academy

Vladikavkaz, Russia

L. Khutieva

North Ossetian State Medical Academy

Vladikavkaz, Russia

L. Osipova

North Ossetian State Medical Academy

Vladikavkaz, Russia

N. Burduli

North Ossetian State Medical Academy

Vladikavkaz, Russia

O. Kotsoeva

North Ossetian State Medical Academy

Vladikavkaz, Russia

T. Bestaeva

Family Medicine Clinic

Vladikavkaz, Russia

参考

  1. Насонов Е.Л. (ред.). Российские клинические рекомендации. Ревматология. М., 2017. 464 с.
  2. Эрдес Ш., Фоломеева О.М. Проблема ревматических заболеваний в России. РМЖ. 2004;12(20):11212.
  3. Rapoport R., Kozin F., Mackel S., et al. Cutaneous vascular immunofluorescence in rheumatoid arthritis. Am. J. Med. 1980;68(3):325-31. Doi: http://dx.doi.org/10.1016/0002-9343(80)90100-X.
  4. Scott D.G., Bacon PA. Systemic rheumatoid vasculitis: a clinical and laborathory study of 50 cases. Med. (Baltimore). 1981;60(4):288-97. Doi: http://dx.doi.org/10.1097/00005792-198107000-00004.
  5. Espinoza L.R., Espinoza C.G., Vasey F.B., Germain B.F. Oral methotrexate therapy for chronic rheumatoid arthritis ulcerations. J. Am Acad Dermatol. 1986;15(3):508-12. Doi: http://dx.doi. org/10.1016/S0190-9622(86)70202-8.
  6. Upchurch K.S., Heller K., Bress N.M. Low-dose methotrexate therapy for cutaneous vasculitis of rheumatoid arthritis. J. Am Acad Dermatol. 1987;17(2 Pt. 2):355-59. doi: 10.1016/s0190-9622(87)70212-6.
  7. Simon G.A., Schmid P., Reifenrath W.G., et al. Wound healing after laser injury to skin - the effect of occlusion and vitamin Eur J. Pharm Sci. 1994;83(8):1101-106. Doi: http://dx.doi. org/10.1002/jps.2600830807.
  8. Combe B., Didry C., Gutierrez M., et al. Accelerated nodulosis and systemic manifestations during methotrexate therapy for rheumatoid arthritis. Eur J. Med. 1993;2(3):153-56.
  9. Chen K.R., Toyohara A., Suzuki A., Miyakawa S. Clinical and histopathological spectrum of cutaneous vasculitis in rheumatoid arthritis. Br J. Dermatol. 2002;147(5):905-13. Doi: http:// dx.doi.org/1 0. 1 046/j. 1365-2133.2002. 04933.x.
  10. Al Attar L., Shaver T. Abatacept as a Therapeutic Option for Rheumatoid Vasculitis. Cureus. 2018;10(4):e2506. doi: 10.7759/cureus.2506.

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Bionika Media, 2019
##common.cookie##